United States Biotechnology & Medical Research

DURECT Corp (DRRX)

Track

Ticker: DRRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for DURECT Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 10 Sep 2025
Value US$155,674.00 | Price 225.69 | Shares 73,586
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-10 2025-09-10 PrS Proposed sale
2.0
JUDITH ROBERTSON

Director

Non-Executive Director
73,586
225.69
US$155,674 		73,586 225.69 US$155,674
2025-08-26 2025-08-22 B Purchase
ASEN R SCOTT
Large shareholder
33,566 +41.5%
135.99
US$2,271,052 		33,566 +41.5% 135.99 US$2,271,052
2025-08-22 2025-08-21 B Purchase
ASEN R SCOTT
Large shareholder
61,684 +37.3%
377.72
US$2,855,343 		61,684 +37.3% 377.72 US$2,855,343
2025-08-22 2025-08-20 B Purchase
ASEN R SCOTT
Large shareholder
87,608 +9.9%
1.89
US$165,360 		87,608 +9.9% 1.89 US$165,360
2022-08-22 2022-08-19 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
9,412 +2.7%
0.85
US$8,000 		9,412 +2.7% 0.85 US$8,000
2022-08-22 2022-08-18 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
71,531 +26.0%
0.85
US$60,794 		71,531 +26.0% 0.85 US$60,794
2022-08-19 2022-08-17 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
8,130 +3.0%
0.85
US$6,906 		8,130 +3.0% 0.85 US$6,906
2022-08-19 2022-08-17 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
2,059 +0.8%
0.83
US$1,709 		2,059 +0.8% 0.83 US$1,709
2022-08-12 2022-08-12 B Purchase
1.2
Maderis Gail J
Non-Executive Director
25,204 +14.4%
0.71
US$17,993 		25,204 +14.4% 0.71 US$17,993
2022-08-11 2022-08-11 B Purchase
1.2
Maderis Gail J
Non-Executive Director
24,796 +16.5%
0.70
US$17,322 		24,796 +16.5% 0.70 US$17,322
2022-08-11 2022-08-10 B Purchase
1.2
Maderis Gail J
Non-Executive Director
79,693 +113.4%
0.69
US$54,661 		79,693 +113.4% 0.69 US$54,661
2022-08-11 2022-08-09 B Purchase
1.2
Maderis Gail J
Non-Executive Director
70,307 +inf%
0.64
US$45,158 		70,307 +inf% 0.64 US$45,158
2022-05-27 2022-05-26 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
65,000 +32.5%
0.39
US$25,597 		65,000 +32.5% 0.39 US$25,597
2022-05-25 2022-05-24 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
5,000 +9.1%
0.39
US$1,950 		5,000 +9.1% 0.39 US$1,950
2022-05-25 2022-05-24 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
10,000 +22.2%
0.39
US$3,889 		10,000 +22.2% 0.39 US$3,889
2022-05-25 2022-05-24 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
5,000 +12.5%
0.38
US$1,894 		5,000 +12.5% 0.38 US$1,894
2022-05-25 2022-05-24 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
5,000 +14.3%
0.39
US$1,942 		5,000 +14.3% 0.39 US$1,942
2022-05-25 2022-05-24 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
5,000 +16.7%
0.39
US$1,962 		5,000 +16.7% 0.39 US$1,962
2022-05-18 2022-05-18 B Purchase
3.7
Farfel Gail M
Non-Executive Director
29,911 +42.7%
0.41
US$12,201 		29,911 +42.7% 0.41 US$12,201
2022-05-18 2022-05-17 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
1,800 +6.4%
0.42
US$758 		1,800 +6.4% 0.42 US$758
2022-05-18 2022-05-17 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
8,900 +46.1%
0.42
US$3,749 		8,900 +46.1% 0.42 US$3,749
2022-05-18 2022-05-17 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
9,300 +93.0%
0.42
US$3,899 		9,300 +93.0% 0.42 US$3,899
2022-05-18 2022-05-16 B Purchase
3.7
Farfel Gail M
Non-Executive Director
25,300 +56.5%
0.39
US$9,811 		25,300 +56.5% 0.39 US$9,811
2022-05-18 2022-05-16 B Purchase
3.8
AZAB MOHAMMAD
Non-Executive Director
10,000 +inf%
0.38
US$3,767 		10,000 +inf% 0.38 US$3,767
2022-05-13 2022-05-13 B Purchase
3.7
Farfel Gail M
Non-Executive Director
9,250 +26.0%
0.40
US$3,700 		9,250 +26.0% 0.40 US$3,700
2022-05-13 2022-05-12 B Purchase
3.7
Farfel Gail M
Non-Executive Director
1,500 +4.4%
0.39
US$585 		1,500 +4.4% 0.39 US$585
2022-05-13 2022-05-11 B Purchase
3.7
Farfel Gail M
Non-Executive Director
9,950 +41.3%
0.40
US$3,973 		9,950 +41.3% 0.40 US$3,973
2022-05-12 2022-05-10 B Purchase
3.7
Farfel Gail M
Non-Executive Director
2,339 +10.8%
0.41
US$950 		2,339 +10.8% 0.41 US$950
2022-05-10 2022-05-10 B Purchase
3.7
Farfel Gail M
Non-Executive Director
4,250 +24.3%
0.40
US$1,679 		4,250 +24.3% 0.40 US$1,679
2022-05-10 2022-05-09 B Purchase
3.7
Farfel Gail M
Non-Executive Director
17,500 +inf%
0.39
US$6,906 		17,500 +inf% 0.39 US$6,906
2022-03-16 2022-03-14 B Purchase
2.0
Robertson Judith J.
Non-Executive Director
200,000 +inf%
0.59
US$118,000 		200,000 +inf% 0.59 US$118,000
2024-09-11 2021-12-10 S Sale
3.3
Sussman Norman

Chief Medical Officer

Officer
9,000 -100.0%
1.06
US$9,495 		9,000 -100.0% 1.06 US$9,495
2021-12-09 2021-12-07 B Purchase
2.9
BENITO SIMON X
Non-Executive Director
20,000 +23.5%
1.02
US$20,360 		20,000 +23.5% 1.02 US$20,360
2021-05-17 2021-05-14 PlS Planned sale
Joice Judy R

Sr. VP Operations & Corp QA

Officer
60,137 -63.3%
1.72
US$103,682 		60,137 -63.3% 1.72 US$103,682
2020-09-02 2020-09-01 S Sale
3.1
Bleichroeder LP
Large shareholder
250,000 -0.9%
1.68
US$420,000 		250,000 -0.9% 1.68 US$420,000
2020-06-05 2020-06-03 PlS Planned sale
Joice Judy R

Sr. VP Operations & Corp QA

Officer
22,956 -41.2%
2.45
US$56,284 		22,956 -41.2% 2.45 US$56,284
2020-06-05 2020-06-03 PlS Planned sale
Joice Judy R

Sr. VP Operations & Corp QA

Officer
34,864 -51.6%
2.45
US$85,480 		34,864 -51.6% 2.45 US$85,480
2020-05-28 2020-05-26 S Sale
3.1
Bleichroeder LP
Large shareholder
39,388 -0.1%
2.50
US$98,525 		39,388 -0.1% 2.50 US$98,525
2020-02-06 2020-02-06 B Purchase
3.1
Bleichroeder LP
Large shareholder
75,000 +0.3%
1.65
US$123,622 		75,000 +0.3% 1.65 US$123,622
2020-02-06 2020-02-05 B Purchase
3.1
Bleichroeder LP
Large shareholder
74,998 +0.3%
1.69
US$126,777 		74,998 +0.3% 1.69 US$126,777
2020-02-06 2020-02-04 B Purchase
3.1
Bleichroeder LP
Large shareholder
77,500 +0.3%
1.70
US$131,510 		77,500 +0.3% 1.70 US$131,510
2019-06-24 2019-06-20 B Purchase
3.4
First Eagle Investment Management, LLC
Large shareholder
4,000,000 +17.8%
0.52
US$2,080,000 		4,000,000 +17.8% 0.52 US$2,080,000
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
2,900 +2.0%
0.56
US$1,623 		2,900 +2.0% 0.56 US$1,623
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
74 +0.1%
0.56
US$41 		74 +0.1% 0.56 US$41
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
626 +0.4%
0.56
US$350 		626 +0.4% 0.56 US$350
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
3,449 +2.4%
0.56
US$1,922 		3,449 +2.4% 0.56 US$1,922
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
1,400 +1.0%
0.55
US$775 		1,400 +1.0% 0.55 US$775
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
400 +0.3%
0.55
US$221 		400 +0.3% 0.55 US$221
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
1,800 +1.3%
0.55
US$993 		1,800 +1.3% 0.55 US$993
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
300 +0.2%
0.55
US$165 		300 +0.2% 0.55 US$165
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
500 +0.4%
0.55
US$275 		500 +0.4% 0.55 US$275
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
1,400 +1.0%
0.55
US$764 		1,400 +1.0% 0.55 US$764
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
300 +0.2%
0.55
US$164 		300 +0.2% 0.55 US$164
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
1,751 +1.3%
0.55
US$955 		1,751 +1.3% 0.55 US$955
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
100 +0.1%
0.55
US$55 		100 +0.1% 0.55 US$55
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
7,898 +6.2%
0.54
US$4,304 		7,898 +6.2% 0.54 US$4,304
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
100 +0.1%
0.54
US$54 		100 +0.1% 0.54 US$54
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
300 +0.2%
0.54
US$163 		300 +0.2% 0.54 US$163
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
15 +0.0%
0.54
US$8 		15 +0.0% 0.54 US$8
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
200 +0.2%
0.54
US$109 		200 +0.2% 0.54 US$109
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
1,200 +1.0%
0.54
US$653 		1,200 +1.0% 0.54 US$653
2019-06-11 2019-06-10 B Purchase
3.1
SAXE JON S
287 +0.2%
0.54
US$156 		287 +0.2% 0.54 US$156
2019-05-28 2019-05-24 B Purchase
3.1
SAXE JON S
Non-Executive Director
4,600 +3.8%
0.63
US$2,899 		4,600 +3.8% 0.63 US$2,899
2019-05-28 2019-05-24 B Purchase
3.1
SAXE JON S
Non-Executive Director
21,335 +21.5%
0.63
US$13,443 		21,335 +21.5% 0.63 US$13,443
2019-05-28 2019-05-24 B Purchase
3.1
SAXE JON S
Non-Executive Director
4,065 +4.3%
0.63
US$2,561 		4,065 +4.3% 0.63 US$2,561
2019-05-15 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
2,200 +2.4%
0.71
US$1,558 		2,200 +2.4% 0.71 US$1,558
2019-05-15 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
6,500 +7.5%
0.70
US$4,581 		6,500 +7.5% 0.70 US$4,581
2019-05-15 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
900 +1.1%
0.70
US$634 		900 +1.1% 0.70 US$634
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
800 +0.9%
0.70
US$563 		800 +0.9% 0.70 US$563
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
2,085 +2.5%
0.70
US$1,465 		2,085 +2.5% 0.70 US$1,465
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
37 +0.0%
0.70
US$26 		37 +0.0% 0.70 US$26
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
3,900 +5.0%
0.70
US$2,737 		3,900 +5.0% 0.70 US$2,737
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
1,798 +2.3%
0.70
US$1,260 		1,798 +2.3% 0.70 US$1,260
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
1,600 +2.1%
0.70
US$1,121 		1,600 +2.1% 0.70 US$1,121
2019-05-14 2019-05-13 B Purchase
3.1
SAXE JON S
Non-Executive Director
4,826 +6.9%
0.70
US$3,382 		4,826 +6.9% 0.70 US$3,382
Explore more

More insider trading research around DURECT Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America